(Z)-N,N'-(3-Methoxy-6-(3,4,5-trimethoxystyryl)-1,2-phenylene)bis(2-aminoacetamide) dihydrochloride

ID: ALA3763245

Chembl Id: CHEMBL3763245

PubChem CID: 127025066

Max Phase: Preclinical

Molecular Formula: C22H30Cl2N4O6

Molecular Weight: 444.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)c(NC(=O)CN)c1NC(=O)CN.Cl.Cl

Standard InChI:  InChI=1S/C22H28N4O6.2ClH/c1-29-15-8-7-14(20(25-18(27)11-23)21(15)26-19(28)12-24)6-5-13-9-16(30-2)22(32-4)17(10-13)31-3;;/h5-10H,11-12,23-24H2,1-4H3,(H,25,27)(H,26,28);2*1H/b6-5-;;

Standard InChI Key:  ZRQKHIROMOMIBN-XNOMRPDFSA-N

Associated Targets(Human)

NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Leucine aminopeptidase (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.49Molecular Weight (Monoisotopic): 444.2009AlogP: 1.69#Rotatable Bonds: 10
Polar Surface Area: 147.16Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.20CX Basic pKa: 8.28CX LogP: 0.31CX LogD: -1.05
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.40Np Likeness Score: -0.06

References

1. Devkota L, Lin CM, Strecker TE, Wang Y, Tidmore JK, Chen Z, Guddneppanavar R, Jelinek CJ, Lopez R, Liu L, Hamel E, Mason RP, Chaplin DJ, Trawick ML, Pinney KG..  (2016)  Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.,  24  (5): [PMID:26852340] [10.1016/j.bmc.2016.01.007]

Source